XM does not provide services to residents of the United States of America.
H
H

Hologic


News

U.S. STOCKS Tempus AI, AeroVironment, Gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, AeroVironment, Gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were flat on Thursday, as investors assessed a string of economic data ahead of the Federal Reserve's closely watched inflation report, while Micron and pharmacy chain Walgreens Boots Alliance slumped on disappointing forecasts.
B
G
H
M
N
S
W
U
U
T
C
M

U.S. STOCKS Verona Pharma, McCormick, gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Verona Pharma, McCormick, gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq slightly fell while other indexes were flat to slightly higher on Thursday, as a dip in Treasury yields after a string of economic data boosted megacap stocks.
B
G
H
M
S
W
U
U
T
M

U.S. STOCKS Elanco Animal Health, Levi Strauss, SM Energy

BUZZ-U.S. STOCKS ON THE MOVE-Elanco Animal Health, Levi Strauss, SM Energy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slipped on Thursday as a slump in Micron Technology after a lackluster forecast dragged down other semiconductor stocks, while caution ahead of economic data and a presidential debate also dented sentiment.
H
M
W
U
T

U.S. STOCKS International Paper, U.S. Bancorp, Micron Technology

BUZZ-U.S. STOCKS ON THE MOVE-International Paper, U.S. Bancorp, Micron Technology Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slipped on Thursday as a slump in Micron Technology after a lackluster forecast dragged down other semiconductor stocks, while caution ahead of economic data and a presidential debate also dented sentiment.
H
M
W
U

Stephens starts Hologic with 'overweight' on balance sheet, M&A potential

BUZZ-Stephens starts Hologic with 'overweight' on balance sheet, M&A potential ** Stephens starts Hologic HOLX.O with "overweight", citing the women's health diagnostic equipment maker's strong balance sheet, low leverage ratio and potential for M&A ** Sets TP of $87 vs stock's last close of $72.27; stock flat in premarket trading ** "With leverage
H

U.S. Carnival, FedEx, Micron Technology

U.S. RESEARCH ROUNDUP-Carnival, FedEx, Micron Technology June 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Carnival, FedEx and Micron Technology, on Thursday. HIGHLIGHTS * Carnival Corp CCL.N : Macquarie raises target price to $25 from $24 * FedEx Corp FDX.N : Daiwa Capital Markets raises target price to $318 from $296 * Micron Technology Inc MU.O : JP Morgan raises target price to $180 from $130 * Unifirst Cor
A
E
G
H
H
M
N
S
A
C
C
E

Australia's Lumos Diagnostics jumps on $5 mln payment

BUZZ-Australia's Lumos Diagnostics jumps on $5 mln payment ** Shares of Lumos Diagnostics LDX.AX rise as much as 21.6% to A$0.045, set for its best day since Jan. 11 if gains hold ** Healthcare tech co says it has received a second payment of US$5.0 million from Hologic HOLX.O under the intellectual property (IP) agreement announced on 11 Jan. ** I
H

FDA classifies recall of Hologic's implant as 'most serious'

UPDATE 1-FDA classifies recall of Hologic's implant as 'most serious' Adds detail and background in paragraphs 2 to 6 May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's HOLX.O devices that are implanted in soft tissue such as breast tissue as "most serious", and urged doctors to more actively monitor for side-effects.
H

FDA classifies recall of Hologic's implants for soft tissue as 'most serious'

FDA classifies recall of Hologic's implants for soft tissue as 'most serious' May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's HOLX.O devices that are implanted in soft tissue such as breast tissue as "most serious". Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber
H

U.S. Paramount Global, Sprout Social, Williams-Sonoma

U.S. RESEARCH ROUNDUP- Paramount Global, Sprout Social, Williams-Sonoma May 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Paramount Global, Sprout Social and Williams-Sonoma ,on Friday. HIGHLIGHTS * Expedia Group Inc EXPE.O : Piper Sandler cuts to neutral from overweight * Paramount Global PARA.O : Seaport Research Partners cuts to neutral from buy * Sprout Social Inc SPT.O : Piper Sandler cuts to neutral from ov
A
A
B
B
C
E
F
H
S
D
T
B
Z
A
B
C
M
T

Hologic posts upbeat second quarter profit

Hologic posts upbeat second quarter profit May 2 (Reuters) - Medical tech company Hologic HOLX.O reported second-quarter profit that beat Wall Street estimates on Thursday, sending its shares up 2.8% in extended trading. The Marlborough, Massachusetts-based company manufactures and supplies diagnostic tests and assays, medical imaging systems, and surgical products for women's healthcare.
H

Hologic Inc reports results for the quarter ended in March - Earnings Summary

Hologic Inc reports results for the quarter ended in March - Earnings Summary Hologic Inc HOLX.OQ reported quarterly adjusted earnings of $1.03​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of $1.06. The mean expectation of fifteen analysts for the quarter was for earnings of 98 cents per share.
H

Hologic Q2 Adjusted EBITDA USD 335.6 Million Vs. IBES Estimate USD 324.5 Million

BRIEF-Hologic Q2 Adjusted EBITDA USD 335.6 Million Vs. IBES Estimate USD 324.5 Million May 02 (Reuters) - Hologic Q2 revenue USD 1,017.8 million vs. IBES estimate USD 1,002 million. Q2 gross margin 53.3% Q2 adjusted gross margin 60.7% Q2 operating margin 20.7% Q2 net income USD 169.9 million Q2 adjusted operating margin 30.4% Q2 adjusted net income USD 244.1 million vs.
H

Fed QT taper calms the horses, yen pops again

MORNING BID AMERICAS-Fed QT taper calms the horses, yen pops again A look at the day ahead in U.S. and global markets from Mike Dolan Anxious bond traders seem to have taken solace from the Federal Reserve's surprisingly sharp brake on its "quantitative tightening" process on Wednesday, while the yen capitalized on an easier dollar after what seemed like the second bout of Japanese intervention this week.
A
A
A
C
E
H
I
R
S
U
A
U
I
V
W
Z
A
B
D
H
I
L
P
P
P
T

Hologic Inc <HOLX.OQ> expected to post earnings of 98 cents a share - Earnings Preview

Hologic Inc expected to post earnings of 98 cents a share - Earnings Preview Hologic Inc HOLX.OQ HOLX.O is expected to show a fall in quarterly revenue when it reports results on May 2 for the period ending March 31 2024 The Marlborough Massachusetts-based company is expected to report a 2.4% decrease in revenue to $1.002 billion from $1.03 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.The company's guidance on February 1 2024, for the period ended Mar
H

Hologic To Acquire Endomagnetics Ltd, A Breast Surgical Guidance Company

BRIEF-Hologic To Acquire Endomagnetics Ltd, A Breast Surgical Guidance Company April 29 (Reuters) - Hologic Inc HOLX.O : HOLOGIC TO ACQUIRE ENDOMAGNETICS LTD, A BREAST SURGICAL GUIDANCE COMPANY HOLOGIC INC - PROPOSED DEAL FOR FOR APPROXIMATELY $310 MILLION HOLOGIC- DEAL EXPECTED TO BE SLIGHTLY DILUTIVE TO HOLOGIC'S NON-GAAP EARNINGS PER SHARE IN FI
H



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.